BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer’s Disease Pathology
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer’s Disease Pathology
Authors
Keywords
-
Journal
MOLECULES
Volume 22, Issue 10, Pages 1723
Publisher
MDPI AG
Online
2017-10-13
DOI
10.3390/molecules22101723
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BACE1 regulates the proliferation and cellular functions of Schwann cells
- (2017) Xiangyou Hu et al. GLIA
- BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid Aβ Peptides
- (2017) Kei Sakamoto et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The physiological role of the amyloid precursor protein as an adhesion molecule in the developing nervous system
- (2017) Lucas J. Sosa et al. JOURNAL OF NEUROCHEMISTRY
- Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease
- (2017) Xuan Ye et al. JOURNAL OF NEUROSCIENCE
- Stop Alzheimer’s before it starts
- (2017) Eric McDade et al. NATURE
- Alzheimer's disease as oligomeropathy
- (2017) Kenjiro Ono NEUROCHEMISTRY INTERNATIONAL
- BACE1 across species: a comparison of the in vivo consequences of BACE1 deletion in mice and rats
- (2017) Martin Weber et al. Scientific Reports
- Physiological Functions of the β-Site Amyloid Precursor Protein Cleaving Enzyme 1 and 2
- (2017) Riqiang Yan Frontiers in Molecular Neuroscience
- Amyloid-β as a Modulator of Synaptic Plasticity
- (2017) Mordhwaj S. Parihar et al. JOURNAL OF ALZHEIMERS DISEASE
- RESULTS FROM A FIRST-IN-HUMAN STUDY WITH THE BACE INHIBITOR CNP520
- (2016) Mike Ufer et al. Alzheimers & Dementia
- Dysregulation of intracellular trafficking and endosomal sorting in Alzheimer's disease: controversies and unanswered questions
- (2016) W. H. Toh et al. BIOCHEMICAL JOURNAL
- New directions for protease inhibitors directed drug discovery
- (2016) Yoshio Hamada et al. BIOPOLYMERS
- Alzheimer’s therapy targeting the β-secretase enzyme BACE1: Benefits and potential limitations from the perspective of animal model studies
- (2016) Masuo Ohno BRAIN RESEARCH BULLETIN
- Post-translational regulation of the β-secretase BACE1
- (2016) Wataru Araki BRAIN RESEARCH BULLETIN
- Ion channel regulation by β-secretase BACE1 – enzymatic and non-enzymatic effects beyond Alzheimer's disease
- (2016) Sandra Lehnert et al. Channels
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Mathematical PKPD and safety model of bispecific TfR/BACE1 antibodies for the optimization of antibody uptake in brain
- (2016) Kapil Gadkar et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer’s Disease
- (2016) Gvido Cebers et al. JOURNAL OF ALZHEIMERS DISEASE
- Functions of the Alzheimer’s Disease Protease BACE1 at the Synapse in the Central Nervous System
- (2016) Kathryn M. Munro et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
- (2016) Claudia Cicognola et al. Molecular Neurodegeneration
- Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons
- (2016) Martina Pigoni et al. Molecular Neurodegeneration
- Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer’s disease
- (2016) Riqiang Yan et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- The BACE1 inhibitor verubecestat (MK-8931) reduces CNS -amyloid in animal models and in Alzheimers disease patients
- (2016) M. E. Kennedy et al. Science Translational Medicine
- Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease
- (2016) Deepak Kumar Vijaya Kumar et al. Science Translational Medicine
- BACE1 Physiological Functions May Limit Its Use as Therapeutic Target for Alzheimer's Disease
- (2016) Soraia Barão et al. TRENDS IN NEUROSCIENCES
- Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors
- (2016) Andrea M. Zuhl et al. Nature Communications
- Mechanisms of Aβ Clearance and Degradation by Glial Cells
- (2016) Miriam Ries et al. Frontiers in Aging Neuroscience
- Proteomic Substrate Identification for Membrane Proteases in the Brain
- (2016) Stephan A. Müller et al. Frontiers in Molecular Neuroscience
- Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
- (2016) Riqiang Yan Translational Neurodegeneration
- Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014
- (2015) Michael W. Weiner et al. Alzheimers & Dementia
- Potential role of antimicrobial peptides in the early onset of Alzheimer's disease
- (2015) Mick M. Welling et al. Alzheimers & Dementia
- Pharmacological Inhibition of BACE1 Impairs Synaptic Plasticity and Cognitive Functions
- (2015) Severin Filser et al. BIOLOGICAL PSYCHIATRY
- Prospects of β-Secretase Inhibitors for the Treatment of Alzheimer’s Disease
- (2015) Arun K. Ghosh et al. ChemMedChem
- Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer’s Disease
- (2015) Robert Baranello et al. Current Alzheimer Research
- An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease
- (2015) Y. Kizuka et al. EMBO Molecular Medicine
- -Secretase BACE1 Regulates Hippocampal and Reconstituted M-Currents in a -Subunit-Like Fashion
- (2015) S. Hessler et al. JOURNAL OF NEUROSCIENCE
- Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease
- (2015) Sergio T. Ferreira et al. Frontiers in Cellular Neuroscience
- The A673T mutation in the amyloid precursor protein reduces the production of β-amyloid protein from its β-carboxyl terminal fragment in cells
- (2015) Asuka Kokawa et al. Acta Neuropathologica Communications
- Computational Methods in the Discovery and Design of BACE-1 Inhibitors
- (2015) P. Kacker et al. CURRENT MEDICINAL CHEMISTRY
- CSF amyloid lowering in human volunteers after 14 days’ oral administration of the novel BACE1 inhibitor E2609
- (2014) Bruce Albala et al. Alzheimers & Dementia
- A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease
- (2014) Eric Karran et al. ANNALS OF NEUROLOGY
- BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease
- (2014) Arun K. Ghosh et al. CHEMICAL SOCIETY REVIEWS
- Molecular Mechanisms of Alzheimer Disease Protection by the A673T Allele of Amyloid Precursor Protein
- (2014) Janice A. Maloney et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects
- (2014) Robert Vassar et al. JOURNAL OF NEUROCHEMISTRY
- Targeting the β secretase BACE1 for Alzheimer's disease therapy
- (2014) Riqiang Yan et al. LANCET NEUROLOGY
- Investigation of an amyloid precursor protein protective mutation (A673T) in a North American case-control sample of late-onset Alzheimer's disease
- (2014) Mikhil N. Bamne et al. NEUROBIOLOGY OF AGING
- Inhibition of Amyloid Precursor Protein Processing Leads to Downregulation of Apoptotic Genes in Alzheimer's Disease Animal Models
- (2014) Inna Rabinovich-Nikitin et al. Neurodegenerative Diseases
- Sorting the Role of SORLA in Alzheimer's Disease
- (2014) V. Buggia-Prevot et al. Science Translational Medicine
- BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
- (2014) Robert Vassar Alzheimers Research & Therapy
- A Paired RNAi and RabGAP Overexpression Screen Identifies Rab11 as a Regulator of β-Amyloid Production
- (2014) Vinod Udayar et al. Cell Reports
- On the Interaction of β-Amyloid Peptides and α7-Nicotinic Acetylcholine Receptors in Alzheimer’s Disease
- (2013) Murat Oz et al. Current Alzheimer Research
- Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story
- (2013) Andrew Stamford et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Allosteric inhibition of BACE1 by an exosite-binding antibody
- (2013) Weiru Wang et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles
- (2013) Cyril Cheret et al. EMBO JOURNAL
- Two phases of disulfide bond formation have differing requirements for oxygen
- (2013) Marianne Koritzinsky et al. JOURNAL OF CELL BIOLOGY
- Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer’s Disease
- (2013) Jing Yuan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Loss of Bace2 in zebrafish affects melanocyte migration and is distinct from Bace1 knock out phenotypes
- (2013) Frauke van Bebber et al. JOURNAL OF NEUROCHEMISTRY
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- The role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease
- (2013) Xiaofang Cheng et al. NEUROBIOLOGY OF AGING
- BACE1 Regulates Hippocampal Astrogenesis via the Jagged1-Notch Pathway
- (2013) Xiangyou Hu et al. Cell Reports
- Biochemistry of Amyloid -Protein and Amyloid Deposits in Alzheimer Disease
- (2013) C. L. Masters et al. Cold Spring Harbor Perspectives in Medicine
- Novel peptidomimetics as BACE-1 inhibitors: Synthesis, molecular modeling, and biological studies
- (2012) Stefania Butini et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- IL-1 receptor 2 (IL-1R2) and its role in immune regulation
- (2012) Vanessa A. Peters et al. BRAIN BEHAVIOR AND IMMUNITY
- Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons
- (2012) Peer-Hendrik Kuhn et al. EMBO JOURNAL
- β-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment
- (2012) Jun Cai et al. EMBO Molecular Medicine
- β-Site Amyloid Precursor Protein (APP)-cleaving Enzyme 1 (BACE1)-deficient Mice Exhibit a Close Homolog of L1 (CHL1) Loss-of-function Phenotype Involving Axon Guidance Defects
- (2012) Brian Hitt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BACE1 Protein Endocytosis and Trafficking Are Differentially Regulated by Ubiquitination at Lysine 501 and the Di-leucine Motif in the Carboxyl Terminus
- (2012) Eugene L. Kang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study
- (2012) Eric M Reiman et al. LANCET NEUROLOGY
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
- (2012) Thorlakur Jonsson et al. NATURE
- The precision of axon targeting of mouse olfactory sensory neurons requires the BACE1 protease
- (2012) Luxiang Cao et al. Scientific Reports
- The Membrane-Bound Aspartyl Protease BACE1: Molecular and Functional Properties in Alzheimer’s Disease and Beyond
- (2012) Bastian Dislich et al. Frontiers in Physiology
- Inhibition of β-Secretasein Vivovia Antibody Binding to Unique Loops (D and F) of BACE1
- (2011) Lujia Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cleavage of Neuregulin-1 by BACE1 or ADAM10 Protein Produces Differential Effects on Myelination
- (2011) Xiaoyang Luo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Developing β-secretase inhibitors for treatment of Alzheimer’s disease
- (2011) Arun K. Ghosh et al. JOURNAL OF NEUROCHEMISTRY
- The Alzheimer's β-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb
- (2011) Tharinda W Rajapaksha et al. Molecular Neurodegeneration
- Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift
- (2011) Todd E. Golde et al. NEURON
- Soluble amyloid -protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
- (2011) M. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid- Production in Vivo
- (2011) J. K. Atwal et al. Science Translational Medicine
- Principles of early drug discovery
- (2010) JP Hughes et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Upside of APP at Synapses
- (2010) Hyang-Sook Hoe et al. CNS Neuroscience & Therapeutics
- Ubiquitin Regulates GGA3-mediated Degradation of BACE1
- (2010) Eugene L. Kang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of Low Molecular Weight Pyroglutamate Aβ Oligomers in Alzheimer Disease
- (2010) Oliver Wirths et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BACE1 Deficiency Causes Altered Neuronal Activity and Neurodegeneration
- (2010) X. Hu et al. JOURNAL OF NEUROSCIENCE
- BACE1-/- mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization
- (2010) Brian D. Hitt et al. Molecular Neurodegeneration
- The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
- (2010) Stephanie J. Soscia et al. PLoS One
- Truncated -amyloid peptide channels provide an alternative mechanism for Alzheimer's Disease and Down syndrome
- (2010) H. Jang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crystal structure of human pepsin and its complex with pepstatin
- (2010) Masao Fujinaga et al. PROTEIN SCIENCE
- Predicting memapsin 2 (β-secretase) hydrolytic activity
- (2010) Xiaoman Li et al. PROTEIN SCIENCE
- Decreased Clearance of CNS -Amyloid in Alzheimer's Disease
- (2010) K. G. Mawuenyega et al. SCIENCE
- The basics of preclinical drug development for neurodegenerative disease indications
- (2009) Karen L Steinmetz et al. BMC Neurology
- Dissociating -Amyloid from 7 Nicotinic Acetylcholine Receptor by a Novel Therapeutic Agent, S 24795, Normalizes 7 Nicotinic Acetylcholine and NMDA Receptor Function in Alzheimer's Disease Brain
- (2009) H.-Y. Wang et al. JOURNAL OF NEUROSCIENCE
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Multifunctional aspartic peptidase prosegments
- (2009) Yasumi Horimoto et al. New Biotechnology
- Identification of β-Secretase (BACE1) Substrates Using Quantitative Proteomics
- (2009) Matthew L. Hemming et al. PLoS One
- Design of Potent Aspartic Protease Inhibitors to Treat Various Diseases
- (2008) Jeffrey-Tri Nguyen et al. ARCHIV DER PHARMAZIE
- Requirements for a lead compound to become a clinical candidate
- (2008) Franz F Hefti BMC NEUROSCIENCE
- Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves
- (2008) Xiangyou Hu et al. FASEB JOURNAL
- p3 peptide, a truncated form of Aβ devoid of synaptotoxic effect, does not assemble into soluble oligomers
- (2008) Fabienne Dulin et al. FEBS LETTERS
- Alzheimer Disease Aβ Production in the Absence ofS-Palmitoylation-dependent Targeting of BACE1 to Lipid Rafts
- (2008) Kulandaivelu S. Vetrivel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Two Endoplasmic Reticulum (ER)/ER Golgi Intermediate Compartment-based Lysine Acetyltransferases Post-translationally Regulate BACE1 Levels
- (2008) Mi Hee Ko et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1α
- (2008) Michela Guglielmotto et al. JOURNAL OF NEUROCHEMISTRY
- The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective
- (2008) Solomon S Shaftel et al. Journal of Neuroinflammation
- BACE1 Knock-Outs Display Deficits in Activity-Dependent Potentiation of Synaptic Transmission at Mossy Fiber to CA3 Synapses in the Hippocampus
- (2008) H. Wang et al. JOURNAL OF NEUROSCIENCE
- Flotillin-Dependent Clustering of the Amyloid Precursor Protein Regulates Its Endocytosis and Amyloidogenic Processing in Neurons
- (2008) A. Schneider et al. JOURNAL OF NEUROSCIENCE
- Crystal Structure of an Active Form of BACE1, an Enzyme Responsible for Amyloid Protein Production
- (2008) H. Shimizu et al. MOLECULAR AND CELLULAR BIOLOGY
- Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests
- (2008) K A Bates et al. MOLECULAR PSYCHIATRY
- Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology
- (2008) Stephan Schilling et al. NATURE MEDICINE
- Non-proteolytic effect of β-site APP-cleaving enzyme 1 (BACE1) on sodium channel function
- (2008) Tobias Huth et al. NEUROBIOLOGY OF DISEASE
- β-Secretase as a therapeutic target for Alzheimer’s disease
- (2008) Arun K. Ghosh et al. Neurotherapeutics
- Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice
- (2008) A. V. Savonenko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BACE1 gene deletion: Impact on behavioral function in a model of Alzheimer's disease
- (2007) Dione Kobayashi et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now